Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125984493 | 12598449 | 3 | F | 20160225 | 20160805 | 20160727 | 20160812 | EXP | CN-SA-2016SA132290 | AVENTIS | 18.00 | YR | A | M | Y | 0.00000 | 20160812 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125984493 | 12598449 | 1 | PS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | ROUTE : IV GTT | U | UNK | 103869 | 250 | MG | |||||||
| 125984493 | 12598449 | 2 | SS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | ROUTE : IV GTT | U | UNK | 103869 | 250 | MG | |||||||
| 125984493 | 12598449 | 3 | SS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | ROUTE: IV GTT | U | UNK | 103869 | 100 | MG | INTRAVENOUS INFUSION | ||||||
| 125984493 | 12598449 | 4 | SS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | ROUTE: IV GTT | U | UNK | 103869 | 100 | MG | INTRAVENOUS INFUSION | ||||||
| 125984493 | 12598449 | 5 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | ROUTE: INTRAVENOUS PUMP | Y | UNK | 0 | |||||||||
| 125984493 | 12598449 | 6 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | ROUTE: INTRAVENOUS PUMP | Y | UNK | 0 | |||||||||
| 125984493 | 12598449 | 7 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | ROUTE: INTRAVENOUS PUMP | Y | UNK | 0 | |||||||||
| 125984493 | 12598449 | 8 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | ROUTE: INTRAVENOUS PUMP | Y | UNK | 0 | |||||||||
| 125984493 | 12598449 | 9 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125984493 | 12598449 | 10 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 125984493 | 12598449 | 11 | C | IMMUNOGLOBULIN HUMAN NORMAL | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125984493 | 12598449 | 1 | Intestine transplant rejection |
| 125984493 | 12598449 | 2 | Graft versus host disease |
| 125984493 | 12598449 | 3 | Intestine transplant rejection |
| 125984493 | 12598449 | 4 | Graft versus host disease |
| 125984493 | 12598449 | 5 | Immunosuppressant drug therapy |
| 125984493 | 12598449 | 6 | Prophylaxis against graft versus host disease |
| 125984493 | 12598449 | 7 | Immunosuppressant drug therapy |
| 125984493 | 12598449 | 8 | Prophylaxis against graft versus host disease |
| 125984493 | 12598449 | 9 | Allergy prophylaxis |
| 125984493 | 12598449 | 10 | Prophylaxis against graft versus host disease |
| 125984493 | 12598449 | 11 | Prophylaxis against graft versus host disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125984493 | 12598449 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125984493 | 12598449 | Epilepsy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125984493 | 12598449 | 1 | 20160208 | 20160209 | 0 | |
| 125984493 | 12598449 | 2 | 20160208 | 20160209 | 0 | |
| 125984493 | 12598449 | 3 | 20160310 | 0 | ||
| 125984493 | 12598449 | 4 | 20160310 | 0 | ||
| 125984493 | 12598449 | 5 | 201504 | 20160225 | 0 | |
| 125984493 | 12598449 | 6 | 201504 | 20160225 | 0 | |
| 125984493 | 12598449 | 7 | 20160310 | 0 | ||
| 125984493 | 12598449 | 8 | 20160310 | 0 | ||
| 125984493 | 12598449 | 9 | 201602 | 0 |